Currently, Sunshine Biopharma Inc’s (SBFM) stock is trading at $2.50, marking a gain of 17.85% from last night’s close. At this price, the stock is -99.61% below its 52-week high of $637.20 and 18.66% above its 52-week low of $2.11. Based on the past 30-day period, the stock price is -12.42% below the high and +30.60% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, SBFM’s SMA-200 is $39.67.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As well, it is important to consider SBFM stock ratios such as price-to-sales, which is currently 0.15.SBFM’s price to book ratio for the most recent quarter was 0.20, resulting in an 0.41 price to cash per share for the period.
How does Sunshine Biopharma Inc (SBFM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Sunshine Biopharma Inc (NASDAQ: SBFM) Ownership Details
I will give a breakdown of the key shareholders in Sunshine Biopharma Inc (SBFM). Recent figures show that the company’s insiders hold 0.23% of shares. A total of 11 institutional investors hold shares in the company, making 1.84% of its stock and 1.85% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Bank of America Corporation holding total of 34.48 shares that make 1.72% of the company’s total number of shares and are currently priced at 87927.0.
The securities firm Nordwand Advisors, LLC holds 500.0 shares of SBFM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.03%, and the holding percentage of shares is valued at 1275.0.
An overview of Sunshine Biopharma Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Sunshine Biopharma Inc (SBFM) traded 848,430 shares per day, with a moving average of $2.63 and price change of -0.27. With the moving average of $2.87 and a price change of -0.05, about 479,502 shares changed hands on average over the past 50 days. Finally, SBFM’s 100-day average volume is 286,679 shares, alongside a moving average of $3.62 and a price change of -3.60.
